...
首页> 外文期刊>Current drug targets-The International journal for timely in-depth reviews on drug targets >Mechanisms of bacterial resistance to antibiotics in infections of COPD patients.
【24h】

Mechanisms of bacterial resistance to antibiotics in infections of COPD patients.

机译:COPD患者感染中细菌对抗生素的耐药机制。

获取原文
获取原文并翻译 | 示例

摘要

A key characteristic of airway inflammation in chronic obstructive pulmonary disease (COPD) is the persistent presence of bacteria in the lower airways. The most commonly isolated bacteria in the lower respiratory tract of COPD patients are nontypeable Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae, with growing evidence of the significance of Pseudomonas aeruginosa infections in severe COPD disease. This review focuses on the antibiotic resistant mechanisms associated with the gram-negative bacteria H. influenzae and M. catarrhalis and comparison with P. aeruginosa infection because of the recent evidence of its significance in patients with severe COPD disease. These mechanisms of resistance to beta-lactams in H. influenzae and M. catarrhalis are mostly associated with serine beta-lactamases of class A type, whereas P. aeruginosa strains exhibit a much broader repertoire with class A-D type mechanisms. Other mechanisms of antibiotic resistance include membrane permeability, efflux pump systems and mutations in antimicrobial targets. Antimicrobial resistance within biofilm matrices appears to be different to the mechanisms observed when the bacteria are in the planktonic state. P. aeruginosa exhibits a more numerous and diverse range of antimicrobial resistance mechanisms in comparison to M. catarrhalis and H. influenzae. The recognition that P. aeruginosa is associated with exacerbations in patients with more severe COPD and that turnover in infecting strains is detected (unlike in cystic fibrosis patients), then further investigation is required to better understand the contribution of antimicrobial resistance and other virulence mechanisms to poor clinical outcomes to improve therapeutic approaches.
机译:慢性阻塞性肺疾病(COPD)中气道炎症的关键特征是下部气道中细菌的持续存在。 COPD患者下呼吸道中最常见的细菌是不可分型的流感嗜血杆菌,卡他莫拉菌和肺炎链球菌,越来越多的证据表明铜绿假单胞菌感染在严重COPD疾病中的重要性。这篇综述着重于革兰氏阴性菌流感嗜血杆菌和卡他分枝杆菌相关的抗生素耐药机制,并与铜绿假单胞菌感染进行了比较,因为最近有证据表明其在重症COPD患者中具有重要意义。这些对流感嗜血杆菌和粘膜炎莫拉氏菌的β-内酰胺类耐药的机制大多与A类A型丝氨酸β-内酰胺酶有关,而铜绿假单胞菌菌株则具有A-D类机制更广泛的库。抗生素耐药性的其他机制包括膜通透性,外排泵系统和抗菌目标的突变。当细菌处于浮游状态时,生物膜基质中的抗药性似乎不同于所观察到的机制。与卡他莫拉氏菌和流感嗜血杆菌相比,铜绿假单胞菌表现出更多和多种范围的抗菌素耐药性机制。认识到铜绿假单胞菌与更严重的COPD患者的病情加重有关,并且可以检测到感染菌株的更新(与囊性纤维化患者不同),然后需要进一步研究以更好地了解抗菌素耐药性和其他毒力机制对临床效果较差,无法改善治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号